• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: June 2023

Pharma & Human Health

Concerto Biosciences Announces Discovery Initiative to Combat Recurrent Vaginal Yeast Infections

June 30, 2023 Microbiome Times

Concerto Biosciences announced the launch of a discovery endeavor to develop a new microbial product for the treatment of vulvovaginal candidiasis (VVC), a vaginal yeast infection that adversely affects 75% of women at some point […]

Pharma & Human Health

Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis

June 28, 2023 Microbiome Times

Freya Biosciences, a trans-Atlantic biotech company specializing in women’s health, announces positive topline results from its first Phase 1 clinical study of its lead asset FB101, an investigational vaginal microbial immunotherapeutic. These data allow the […]

Pharma & Human Health

New “atlas” maps bacteria and metabolites associated with elevated risk of cardiovascular disease

June 26, 2023 Microbiome Times

A Cleveland Clinic research team recently published an “atlas” of metabolites associated with cardiovascular disease in the European Heart Journal. The novel findings provide key details about the routes and potential branching paths taken by bacteria and […]

Finance

New biotech venture PHIOGEN, a spinoff of BCM’s TAILOR Labs

June 22, 2023 Microbiome Times

The new biotech venture PHIOGEN is a spin-off company from Baylor College of Medicine’s TAILOR Labs, one of the United States only academic phage therapy cores with a decade’s worth of revolutionary research related to bacteriophages, viruses that infect […]

Editor's Choice

Proven Complementary Effect of Probiotic Yeast and Bacteria

June 21, 2023 Romane Maillet

  Yeast and bacteria combination for the best of both worlds Yeast and bacteria have been successfully used as probiotic for decades: bacteria, mainly from the Lactobacilli and Bifidobacteria species; and yeast Saccharomyces cerevisiae var. […]

Finance

Azitra, Inc. Announces Closing of Initial Public Offering

June 21, 2023 Microbiome Times

Azitra, Inc. (NYSE American: AZTR) (the “Company”), a biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products, today announced the closing of its initial public offering of […]

Pharma & Human Health

An oral probiotic can treat dry eye disease

June 20, 2023 Microbiome Times

In a study by a research group at Baylor College of Medicine, oral administration of a commercially available probiotic bacterial strain was found to improve dry eye disease in an animal model. The findings were […]

Finance

Metagen Therapeutics Completes Series A Financing Raising a Total of 1.7 Billion Yen

June 19, 2023 Microbiome Times

Metagen Therapeutics, a company focusing on drug discovery and development based on intestinal microbiome-based therapeutics for various diseases, has completed its Series A funding in 2 rounds, raising a total of 1.7 billion yen. Sparx […]

Finance

Verb Biotics announces acquisition of YSOPIA Bioscience health and wellness strains

June 14, 2023 Microbiome Times

Verb Biotics LLC., a microbiome innovation company, today announced that they have acquired YSOPIA Bioscience’s strain and IP portfolio targeted for human health and wellness. The acquisition of YSOPIA’s strain portfolio includes one of the […]

Pharma & Human Health

Scientists and clinicians use AI analysis of the gut microbiome to detect colon cancer

June 12, 2023 Microbiome Times

APC Microbiome Ireland, a world-leading SFI research centre based at UCC (University College Cork), has joined forces with BowelScreen and the Mater Misericordiae University Hospital, as part of 8 partner organisations from 5 European countries […]

Finance

Biocodex fully acquires TargEDys

June 6, 2023 Microbiome Times

TargEDys and Biocodex have been partners since 2019, when Biocodex became a shareholder and board member of TargEDys. Soon after, Biocodex became the distributor of TargEDys’ leading PreciBiomic, Symbiosys Satylia®, in France, then in Portugal […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
  • Proven Complementary Effect of Probiotic Yeast and Bacteria
    June 21, 2023
  • Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks
    May 25, 2023
sign up

Sign up to the Microbiome Times newsletter